Julia Strandberg

Insider Reports History

Location
Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julia Strandberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 1.41M 15 Feb 2023 Direct
Pear Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 78.8K 16 Feb 2022 Direct
Pear Therapeutics, Inc. Chief Commercial Officer Common Stock 41.3K 14 Jan 2023 Direct
Pear Therapeutics, Inc. Chief Commercial Officer Class A Common Stock 28.6K 20 Jan 2023 Direct

Insider Reports Filed by Julia Strandberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PEARQ Pear Therapeutics, Inc. 15 Feb 2023 1 $0 4 Chief Commercial Officer 17 Feb 2023, 15:13
PEARQ Pear Therapeutics, Inc. 20 Jan 2023 1 -$14.3K 4 Chief Commercial Officer 24 Jan 2023, 15:08
PEARQ Pear Therapeutics, Inc. 14 Jan 2023 2 $0 4 Chief Commercial Officer 18 Jan 2023, 16:01
PEARQ Pear Therapeutics, Inc. 16 Feb 2022 2 $0 4 Chief Commercial Officer 18 Feb 2022, 15:42
PEARQ Pear Therapeutics, Inc. 03 Dec 2021 3 $0 4 Chief Commercial Officer 07 Dec 2021, 16:26
PEARQ Pear Therapeutics, Inc. 03 Dec 2021 0 $0 3 Chief Commercial Officer 07 Dec 2021, 16:07